Koyfin Home > Directory > Health Care > Iovance Biotherapeutics Inc > EBITDA

Iovance Biotherapeutics Inc EBITDA Chart (IOVA)

Iovance Biotherapeutics Inc annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Iovance Biotherapeutics Inc EBITDA for the quarter ending June 06, 2020 was $-63m a 19.05% decrease of -12m year over year
  • Iovance Biotherapeutics Inc EBITDA for the last 12 months ending June 06, 2020 was $-250m a 29.78% decrease of -74m year over year
  • Iovance Biotherapeutics Inc Annual EBITDA for 2019 was $-206m a 38.11% decrease of -78m from 2018
  • Iovance Biotherapeutics Inc Annual EBITDA for 2018 was $-127m a 27.79% decrease of -35m from 2017
  • Iovance Biotherapeutics Inc Annual EBITDA for 2017 was $-92m a 53.05% decrease of -49m from 2016
Other Income Statement Metrics:
  • Iovance Biotherapeutics Inc Net Income for the quarter ending December 12, 2018 was $-33m a 18.60% decrease of -6m year over year
View Chart On Koyfin

Quarterly IOVA EBITDA Data

06/2020$-63m
03/2020$-71m
12/2019$-65m
09/2019$-51m
06/2019$-50m
03/2019$-40m
12/2018$-35m
09/2018$-35m
06/2018$-31m
03/2018$-27m

Annual IOVA EBITDA Data

2019$-206m
2018$-127m
2017$-92m
2016$-43m
2015$-27m
2014$-12m
2013$-6m
2012$-8m
2011$-21m
2010$-1m